Obesity clinical trial success rates for novel drugs U.S. 2006-2015 by phase

Published by
Matej Mikulic,
Apr 18, 2019
This statistic depicts the percentage of obesity clinical trials for novel drugs that were successful in the period from 2006 to 2015, by phase and indication. According to the data, among obesity NME/biologics just 1.4 percent were successful from phase I to approval.

Clinical trial success rates for novel obesity drugs between 2006 and 2015, by phase and indication

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2019

Region

United States

Survey time period

2006 to 2015

Supplementary notes

NDA/BLA = new drug application/biologic license application
NME = new molecular entity

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Diabetes in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Diabetes in the U.S.

Overview

4

Prediabetes

6

Prevalence and incidence of diabetes

8

Prepregnancy diabetes

5

Insulin

6

Deaths

4

Risk factor: Obesity

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Diabetes in CanadaDeath in CanadaObesity in CanadaDiabetes in the U.S.Diseases in Canada
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu